Cha Meditech's Research Results on Penis Enlargement Filler Listed in International Journal

The results of the study (HyaFilia Impact) by Cha Meditech (CEO Kim Seok-jin) on penis enlargement filler have recently been listed in the SCIE international journal, the "Journal of Clinical Medicine".

The study compared the product’s effectiveness on 67 patients with dwarfism syndrome between "HyaFilia Impact" (photo) and "Polylactic Acid Filler". The test was conducted at three institutions: Gangdong Sacred Heart Hospital, Chuncheon Sacred Heart Hospital, and Dongtan Sacred Heart Hospital.

According to the results of the study, "HyaFilia Impact" demonstrated significant improvements in penis length and circumference 18 months after the procedure, and it was confirmed that the retention and satisfaction assessment did not differ much compared to the polymer filler.

HyaFilia Impact is hyaluronic acid filler that has obtained item approval from the Ministry of Food and Drug Safety for "temporary penis circumference expansion of men with dwarfism syndrome". Because a large volume of the product is required for this compared with facial treatments, it has been released in various capacities, such as 1ml, 2ml, 3ml, 5ml, and 10ml.

The product is characterized by its high resistance to viscosity, elasticity, and durability by applying Cha Meditech's own technology called the "LTSR (Low Temperature Stabilization Reaction) Method", which increases the density of hyaluronic acid and makes the distance between molecules closer.

In the meantime, facial filler has been frequently used in the form of off-label (used at the discretion of the doctor), and in the case of conventional hyaluronic acid filler, the duration in the body is shorter than that of polymer filler, which also has the disadvantage of reducing the patient's satisfaction.

Kim Seok-jin, CEO of Cha Meditech, said, "The listing in the international journal has proved internationally the excellence of the 'HyaFilia Impact', filler for penile expansion. We will do our best to promote the differentiated values of 'HyaFilia Impact' through marketing with clinically tested results".